Evidence map›Paper›PMID 30253241›Full record

ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2019

Recombinant Pregnancy-Specific Glycoprotein 1 Has a Protective Role in a Murine Model of Acute Graft-versus-Host Disease.

Karlie Jones, Sarah Bryant, Jian Luo, Patricia Kiesler, Sherry Koontz, James Warren, Harry Malech, Elizabeth Kang, Gabriela Dveksler

Open access · hybridAbstract read
In one paragraph

Article in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Activation of immune signals during organ transplantation.Signal transduction and targeted therapy · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Karlie JonesLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Sarah BryantLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Jian LuoPalo Alto Veterans Institute for Research, VA Palo Alto Health Care System, Palo Alto, California.
Patricia KieslerMucosal Immunity Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Sherry KoontzLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
James WarrenDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Harry MalechLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Elizabeth KangLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Gabriela DvekslerDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland. Electronic address: gabriela.dveksler@usuhs.edu.
National Institutes of Health · USNational Institute of Allergy and Infectious Diseases · USUniformed Services University of the Health Sciences · USVA Palo Alto Health Care System · US

Funding

Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for inherited immune deficienciesZIAAI000989 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KANG, ELIZABETH · 2009 to 2025
$12.4M
Gene Therapy Basic Research to Treat Inherited Primary Immune DeficienciesZIAAI000644 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MALECH, HARRY L · 2009 to 2025
$12.1M
Basic Research on Hematopoietic Human Stem CellsZIAAI000988 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MALECH, HARRY L · 2009 to 2019
$6.5M
Gene Therapy Clinical Trials for Chronic Granulomatous DiseaseZIAAI000991 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KANG, ELIZABETH · 2009 to 2019
$3.4M
TGF-β Signaling as a Novel Therapeutic Target for Mild Traumatic Brain InjuryR01NS092868 · NINDS · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI LUO, JIAN · 2016 to 2020
$1.5M
Clinical Trials of Allogeneic Transplantation for Inherited Immune DeficienciesZ01AI000989 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI KANG, ELIZABETH · 2007 to 2008
$878k
Therapeutic potential of PSG1 administration in GVHDR21AI120918 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI DVEKSLER, GABRIELA S · 2016 to 2017
$424k
Intramural NIH HHS Z01 AI000989NIAID NIH HHS R21 AI120918
6 · The paper itself

Abstract

Acute graft-versus-host disease (aGVHD) is an immune-mediated reaction that can occur after hematopoietic stem cell transplantation in which donor T cells recognize the host antigens as foreign, destroying host tissues. Establishment of a tolerogenic immune environment while preserving the immune response to infectious agents is required for successful bone marrow transplantation. Pregnancy-specific glycoprotein 1 (PSG1), which is secreted by the human placenta into the maternal circulation throughout pregnancy, likely plays a role in maintaining immunotolerance to prevent rejection of the fetus by the maternal immune system. We have previously shown that PSG1 activates the latent form of transforming growth factor β1 (TGF-β), a cytokine essential for the differentiation of tolerance-inducing CD4

Indexed as

Bone Marrow TransplantationGraft vs Host DiseaseAcute DiseaseAnimalsDisease Models, AnimalHumansMiceMice, TransgenicPregnancy-Specific beta 1-GlycoproteinsRecombinant ProteinsT-Lymphocytes, RegulatoryTransplantation, HomologousPregnancy-Specific beta 1-GlycoproteinsRecombinant ProteinsGVHDImmunotolerancePregnancy-specific glycoproteinRegulatory T cellTGF-β1

Identifiers

PMID30253241
PMCPMC9490678
OpenAlexW2894047470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.